Regardless of whether it's a merger or takeover we can expect to receive a decent premium on our last closing price right?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025